RxDoctor Payments Data

Jared Harper, PA

Medical · Versailles, KYNPI 1225516644

Payments from drug & device makers

$2,850in general payments, 2019–2025

Across 174 payments — averaging $16.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$398
  • Johnson & Johnson$291
  • Lilly USA, LLC$190
  • Bayer$185
  • Axsome Therapeutics, Inc.$182
  • Otsuka America Pharmaceutical, Inc.$118
  • plus $1K from 36 others

What the payments were for

  • Food & beverage$2,850100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,850 in reported general payments places this provider in the 70th percentile of 222 medical providers in Kentucky.

See all medical providers in Kentucky

Medicare billing

Part B allowed, 2024
$43,023
Medicare patients
87
Services billed
789

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide45$79,359
JardianceEmpagliflozin61$68,185
EliquisApixaban61$57,916
MounjaroTirzepatide47$56,868
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$44,807
EntrestoSacubitril/Valsartan24$25,321
VraylarCariprazine Hcl17$24,193
XareltoRivaroxaban24$21,795
FarxigaDapagliflozin Propanediol11$16,713
TrulancePlecanatide13$14,627
UbrelvyUbrogepant11$11,180
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,601
Nebivolol Hcl32$2,441
Roflumilast13$2,285
Albuterol Sulfate HfaAlbuterol Sulfate83$2,128

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$45$79,35945 claims
Boehringer IngelheimJardiance$14$68,18561 claims
PfizerEliquis$109$57,91661 claims
Lilly USA, LLCMounjaro$190$56,86847 claims
GSKTrelegy Ellipta$113$44,80746 claims
AbbVieVraylar, Ubrelvy$398$35,37328 claims
NovartisEntresto$54$25,32124 claims
AstraZenecaFarxiga, Breztri Aerosphere$28$24,31423 claims
Johnson & JohnsonXarelto$291$21,79524 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$42$14,62713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 222 medical providers in Kentucky.

Other medical in Versailles

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →